Relationship between personality and debrisoquine hydroxylation capacity
- 1 January 1993
- journal article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 87 (1) , 23-28
- https://doi.org/10.1111/j.1600-0447.1993.tb03325.x
Abstract
We administered the Karolinska Scales of Personality to 225 healthy subjects in Spain selected from a group of 925 individuals previously phenotyped with regard to their capacity to hydroxylate debrisoquine. A significant relationship was found between the scores in as many as 4 of the 15 subscales (psychic anxiety, psychasthenia, inhibition of aggression and socialization) and the debrisoquine hydroxylation capacity. Poor metabolizers were more anxiety-prone and less successfully socialized than extensive metabolizers of debrisoquine. This and a previous study among subjects in Sweden suggest that there may be a relationship between personality and the activity of the enzyme hydroxylating debrisoquine (cytochrome P4502D6). This polymorphic enzyme may have an endogenous neuroactive substrate or product, such as a biogenic neurotransmitter amine.Keywords
This publication has 26 references indexed in Scilit:
- Five-year follow-up study of adolescents with intact and restored dentitions: personality traitsJournal of Oral Rehabilitation, 2008
- Stability over time of character assessment using a psychodynamic instrument and personality inventoriesActa Psychiatrica Scandinavica, 1992
- Mutant debrisoquine hydroxylation genes in Parkinson's diseaseThe Lancet, 1992
- SKF 525-A and cytochrome P-450 ligands inhibit with high affinity the binding of [3H]dextromethorpan and σ ligands to guinea pig brain.Life Sciences, 1991
- Is the Sigma Opiate Receptor a Proadifen‐Sensitive Subform of Cytochrome P‐450?Basic & Clinical Pharmacology & Toxicology, 1990
- Sigma binding states in the brain; An emerging concept for multiple sites and their relevance for psychiatric disordersLife Sciences, 1990
- DEBRISOQUINE HYDROXYLATION PHENOTYPES IN HEALTHY VOLUNTEERSThe Lancet, 1989
- MPTP, the neurotoxin inducing parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylationBiochemical and Biophysical Research Communications, 1987
- DEBRISOQUINE METABOLISM IN PARKINSONIAN PATIENTS TREATED WITH ANTIHISTAMINE DRUGSThe Lancet, 1987
- ECOGENETICS OF PARKINSON'S DISEASE: 4-HYDROXYLATION OF DEBRISOQUINEThe Lancet, 1985